Shubham Laboratories (India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 07-12-2024
- Paid Up Capital ₹ 0.10 M
as on 07-12-2024
- Company Age 7 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2021)
- Profit -350.85%
(FY 2021)
- Ebitda -350.85%
(FY 2021)
- Net Worth -201.80%
(FY 2021)
- Total Assets %
(FY 2021)
About Shubham Laboratories (India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Surendra Sharma, Ramchandra Maharshi, and Swapnil Nerkar serve as directors at the Company.
- CIN/LLPIN
U74999MH2017PTC295655
- Company No.
295655
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Jun 2017
- Date of AGM
11 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shubham Laboratories (India)?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Surendra Sharma  | Director | 20-Sep-2024 | Current |
| Ramchandra Maharshi | Director | 01-Jun-2017 | Current |
| Swapnil Nerkar | Director | 01-Jun-2017 | Current |
Financial Performance of Shubham Laboratories (India).
Shubham Laboratories (India) Private Limited, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 350.85% decrease in profit. The company's net worth observed a substantial decline by a decrease of 201.8%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shubham Laboratories (India)?
In 2021, Shubham Laboratories (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Shubham Specialty Products (India) Private LimitedActive 13 years 9 monthsRamchandra Maharshi and Swapnil Nerkar are mutual person
Svar Specialty Private LimitedActive 5 years 2 monthsRamchandra Maharshi and Swapnil Nerkar are mutual person
Rachana Intermediates Private LimitedActive 20 years 2 monthsRamchandra Maharshi is a mutual person
Swapnil Technologies LlpActive 6 years 2 monthsRamchandra Maharshi and Swapnil Nerkar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shubham Laboratories (India)?
Unlock and access historical data on people associated with Shubham Laboratories (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubham Laboratories (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubham Laboratories (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
